BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9160608)

  • 41. Alpha 2-adrenergic receptor sensitivity in panic disorder: II. Cortisol response to clonidine stimulation in panic disorder.
    Brambilla F; Bellodi L; Arancio C; Nobile P; Perna G
    Psychoneuroendocrinology; 1995; 20(1):11-9. PubMed ID: 7838899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generic effectiveness measures: sensitivity to symptom change in anxiety disorders.
    Perini SJ; Slade T; Andrews G
    J Affect Disord; 2006 Feb; 90(2-3):123-30. PubMed ID: 16337690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do panic-agoraphobics overestimate distances?
    Iavarone DA; Del Castello E; Ruggiero G; Iachini T
    World J Biol Psychiatry; 2005; 6(4):242-6. PubMed ID: 16272079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alprazolam-induced panic disorder.
    Bashir A; Swartz C
    J Am Board Fam Pract; 2002; 15(1):69-72. PubMed ID: 11841142
    [No Abstract]   [Full Text] [Related]  

  • 45. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ; Harmatz JS; Shader RI
    Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.
    Curtis GC; Abelson JL; Gold PW
    Biol Psychiatry; 1997 Jan; 41(1):76-85. PubMed ID: 8988798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A naturalistic 6-year follow-up study of patients with panic disorder.
    Lepola U; Koponen H; Leinonen E
    Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug treatment of panic disorder. Reply to comment by Marks and associates.
    Klerman GL
    Br J Psychiatry; 1992 Oct; 161():465-71. PubMed ID: 1309180
    [No Abstract]   [Full Text] [Related]  

  • 51. A naturalistic follow-up of panic patients after short-term pharmacologic treatment.
    Munjack DJ; Brown RA; Cabe DD; McDowell DE; Baltazar PL
    J Clin Psychopharmacol; 1993 Apr; 13(2):156-8. PubMed ID: 8463449
    [No Abstract]   [Full Text] [Related]  

  • 52. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives.
    Cameron OG; Smith CB; Nesse RM; Hill EM; Hollingsworth PJ; Abelson JA; Hariharan M; Curtis GC
    Psychosom Med; 1996; 58(4):289-301. PubMed ID: 8827791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lamotrigine administration in panic disorder with agoraphobia.
    Masdrakis VG; Papadimitriou GN; Oulis P
    Clin Neuropharmacol; 2010 May; 33(3):126-8. PubMed ID: 20502131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Panic symptoms without report of anxiety.
    Schreier H; Martinez K
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):407-8. PubMed ID: 15843761
    [No Abstract]   [Full Text] [Related]  

  • 57. Personality profiles in patients referred for chest pain. Investigation with emphasis on panic disorder patients.
    Dammen T; Ekeberg O; Arnesen H; Friis S
    Psychosomatics; 2000; 41(3):269-76. PubMed ID: 10849460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Childhood trauma and personality disorder in 43 women with panic disorder.
    Moisan D; Engels ML
    Psychol Rep; 1995 Jun; 76(3 Pt 2):1133-4. PubMed ID: 7480477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features of cocaine-induced panic.
    Louie AK; Lannon RA; Rutzick EA; Browne D; Lewis TB; Jones R
    Biol Psychiatry; 1996 Nov; 40(9):938-40. PubMed ID: 8896786
    [No Abstract]   [Full Text] [Related]  

  • 60. Agoraphobia and panic disorder: 3.5 years after alprazolam and/or exposure treatment.
    Kiliç C; Noshirvani H; Başoğlu M; Marks I
    Psychother Psychosom; 1997; 66(4):175-8. PubMed ID: 9259039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.